Navigation Links
Christopher Codeanne Appointed Chief Financial Officer of Premier Research Group
Date:12/16/2010

PHILADELPHIA, Dec. 16, 2010 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointment of Christopher Codeanne to the position of Chief Financial Officer.

Mr. Codeanne has more than 20 years of management, operational, and finance and accounting experience. Prior to joining Premier Research, he was the Chief Operating Officer and Chief Financial Officer of Oncology Development Partners, LLC (d/b/a Oncopartners).  He has also served as the Chief Financial Officer of both Averion International Corp and SCIREX Corporation. Mr. Codeanne serves as a member of the Board of Directors of Cornerstone Therapeutics Inc., a specialty pharmaceutical company.

Mr. Codeanne received an MBA with a concentration in finance from the University of Connecticut and a Bachelor of Science degree in Accounting from Fairfield University. He is a member of the American Institute of Certified Public Accountants, Connecticut Society of Certified Public Accountants and Financial Executives International.  

"We are pleased to have Chris join Premier Research as our Chief Financial Officer. He is a seasoned leader with a proven track record in the industry," said Dr. Ludo Reynders, CEO. "With his skill set and experience, he will be instrumental in directing the finances of the company while facilitating our growth strategy."

About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. With a network of skilled staff operating across North America and Europe and partnerships in Latin America, Asia, South Africa, Australia and the Middle East, Premier Research manages Phase 1-4 trials and programs.

They are leaders in clinical research for analgesia, oncology, neuroscience, and cardiovascular and have a wealth of experience in medical device and pediatric research. They offer a comprehensive selection of services for every phase of clinical development including, regulatory affairs, clinical trial management, clinical research centers, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, IVRS/IWRS, quality assurance, and functional sourcing.

www.premier-research.com


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
2. IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
3. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
4. David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
5. Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks
6. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
7. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
8. Clive Dix Appointed as Chairman of Crescendo Biologics
9. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
10. Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger
11. Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:5/30/2017)... , May 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... data solutions, today announced that it will be presenting at the ... 8:00 AM PT. Erez Raphael , CEO, of DarioHealth will ... conference will be held on June 6th & 7th, 2017 at ... in the small / micro-cap space. ...
(Date:5/26/2017)... BARBARA, Calif. , May 25, 2017  In ... United States , Direct Relief is working with ... overdose-reversing Naloxone available at no cost to community health ... other nonprofit providers nationwide. "Pfizer has ... access to medicines and ensuring patient safety through educational ...
Breaking Medicine Technology:
(Date:6/28/2017)... British Columbia (PRWEB) , ... June 28, 2017 ... ... CNZCF) (FSE: ZEON) is pleased to announce that a two year study conducted ... the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Dianne Michael ... greater Cincinnati metropolitan area, is teaming up with the local chapter of the ... receiving treatment in nearby hospitals. , Ronald McDonald House of Greater Cincinnati, one ...
(Date:6/27/2017)... ... 27, 2017 , ... Nearly 70 percent of consumers now ... by the American Society for Dermatologic Surgery (ASDS). , The ... considering a cosmetic medical procedure has doubled since 2013. , “Cosmetic procedures continue ...
(Date:6/27/2017)... ... 2017 , ... Harbour , a DAO (decentralized autonomous organization) that harnesses ... released their technical specifications . , 2017 has seen an explosion of token ... determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of ...
Breaking Medicine News(10 mins):